- Home
- TRS vs BHVN Comparison
TRS vs BHVN Comparison
Compare TRS & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- BHVN
- Stock Information
- Founded
- TRS 1986
- BHVN 2013
- Country
- TRS United States
- BHVN United States
- Employees
- TRS N/A
- BHVN N/A
- Industry
- TRS Industrial Specialties
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- TRS Industrials
- BHVN Health Care
- Exchange
- TRS Nasdaq
- BHVN Nasdaq
- Market Cap
- TRS 1.5B
- BHVN 1.5B
- IPO Year
- TRS 2007
- BHVN 2017
- Fundamental
- Price
- TRS $38.33
- BHVN $15.66
- Analyst Decision
- TRS Strong Buy
- BHVN Strong Buy
- Analyst Count
- TRS 2
- BHVN 14
- Target Price
- TRS $45.00
- BHVN $54.62
- AVG Volume (30 Days)
- TRS 623.2K
- BHVN 2.4M
- Earning Date
- TRS 07-29-2025
- BHVN 08-11-2025
- Dividend Yield
- TRS 0.42%
- BHVN N/A
- EPS Growth
- TRS N/A
- BHVN N/A
- EPS
- TRS 0.91
- BHVN N/A
- Revenue
- TRS $973,840,000.00
- BHVN N/A
- Revenue This Year
- TRS $6.37
- BHVN N/A
- Revenue Next Year
- TRS $5.49
- BHVN $2,002.87
- P/E Ratio
- TRS $42.15
- BHVN N/A
- Revenue Growth
- TRS 6.72
- BHVN N/A
- 52 Week Low
- TRS $19.33
- BHVN $12.79
- 52 Week High
- TRS $38.56
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- TRS 77.16
- BHVN 56.24
- Support Level
- TRS $36.36
- BHVN $14.23
- Resistance Level
- TRS $37.49
- BHVN $16.14
- Average True Range (ATR)
- TRS 0.83
- BHVN 0.86
- MACD
- TRS 0.01
- BHVN 0.10
- Stochastic Oscillator
- TRS 94.39
- BHVN 85.48
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.